Biodexa Pharmaceuticals PLC Holding(s) in Company (4729W)
17 April 2023 - 11:35PM
UK Regulatory
TIDMBDRX
RNS Number : 4729W
Biodexa Pharmaceuticals PLC
17 April 2023
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to
the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying
issuer of existing shares to which voting Biodexa Pharmaceuticals PLC
rights are at- tached ii :
---------------------------------------
1b. Please indicate if the issuer is a non-UK issuer(please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification(please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights x
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify) iii :
----
3. Details of person subject to the notification obligation iv
Name S.H.N Financial Investments
---------------------------------------
City and country of registered office Herzliya, Israel
(if applicable)
---------------------------------------
4. Full name of shareholder(s)(if different from 3.) v
Name
---------------------------------------
City and country of registered office
(if applicable)
---------------------------------------
5. Date on which the threshold was crossed
or reached vi : 13th of April 2023
6. Date on which issuer notified (DD/MM/YYYY):
13th of April 2023
-------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total number
at- tached to through financial Total of both of voting rights
shares (to- tal instru- ments in % (8.A + 8.B) held in issuer
of 8. A) (total of 8.B 1 (8.A +
+ 8.B 2) 8.B) vii
-------------------- ----------------------- ----------------------- ------------------
Resulting situation
on the date on
which threshold
was crossed or
reached 3.59% 0 3.59% 2620465
-------------------- ----------------------- ----------------------- ------------------
Position of previous
notification (if <3% 0 <3%
applicable)
-------------------- ----------------------- ----------------------- ------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of Number of voting rights ix % of voting rights
shares
ISIN code (if
possible)
------------------------------------------------ -------------------------------------------
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------------- --------------------- --------------------- --------------------
GB00BKT14T00 2620465 3.59%
------------------------- --------------------- --------------------- --------------------
SUBTOTAL 8. A 2620465 3.59%
------------------------------------------------ -------------------------------------------
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Number of voting
Type of financial Expiration Exercise/ Conversion rights that may be % of voting
in- strument date x Period xi acquired if rights
the instrument is
exercised/converted.
--------------- ------------------------------ ---------------------- --------------------
SUBTOTAL 8. B 1
------------------------------ ---------------------- --------------------
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
(1) (b)
Type of financial Expiration Exercise/ Physical or Number of
instrument date x Conversion cash Settlement voting rights % of voting
Pe- riod xi xii rights
----------- ------------- ----------------- --------------- --------------
SUBTOTAL 8.B.2
----------------- --------------- --------------
9. Information in relation to the person subject to the notification obligation(please
mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by
any natural person or legal entity and does not control any other x
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer xiii
------
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary) xiv
------
% of voting rights % of voting rights Total of both if
if it equals or is through financial it equals or is higher
Name xv higher than the notifiable in- struments if than the notifiable
threshold it equals threshold
or is higher than
the notifiable threshold
----------------------------- ---------------------------- -------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-------------------------------------------------------------
The number and % of voting rights held
-------------------------------------------------------------
The date until which the voting rights
will be held
-------------------------------------------------------------
Place of completion UK
Date of completion 13.04.2023
----------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLXDLFFXZLXBBX
(END) Dow Jones Newswires
April 17, 2023 09:35 ET (13:35 GMT)
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Midatech Pharma Plc (London Stock Exchange): 0 recent articles
More Midatech Pharma Plc News Articles